Acute Coronary Syndrome Management

Aspirin Administration

• The American College of Cardiology recommends administering aspirin as soon as possible to patients with suspected acute coronary syndrome (ACS), even without definitive non-ST-elevation myocardial infarction (NSTEMI) diagnosis, due to its minimal risk, rapid onset of action, and proven mortality benefit across all ACS presentations 1, 2
• Aspirin should be given at a dose of 162-325 mg of non-enteric-coated, chewable aspirin immediately upon presentation with suspected ACS, in the absence of true aspirin allergy 1, 3, 4
• The American Heart Association recommends continuing aspirin indefinitely at 81 mg daily maintenance dose once ACS is confirmed 2, 3, 4

Clopidogrel Loading Dose Timing

• The American College of Cardiology recommends administering clopidogrel loading dose (300-600 mg) before diagnostic angiography if NSTEMI diagnosis is likely or definite, and an invasive strategy is planned 2, 5
• The 600 mg loading dose provides more rapid and reliable platelet inhibition compared to 300 mg, according to the American College of Cardiology 5, 2
• Clopidogrel loading dose should be withheld if there is diagnostic uncertainty and prasugrel is being considered after angiography, particularly in percutaneous coronary intervention (PCI) patients without prior stroke or transient ischemic attack (TIA) 1, 4
• The American Heart Association recommends administering clopidogrel loading dose (300-600 mg) followed by 75 mg daily as soon as the NSTEMI diagnosis is established, and continuing for at least 1 month (Level A evidence) and ideally up to 1 year (Level B evidence) 2, 6

Critical Pitfalls to Avoid

• The American College of Cardiology advises against giving clopidogrel loading dose if the diagnosis remains unclear and coronary artery bypass grafting (CABG) is a possibility within the next 5-7 days, due to the increased risk of surgical bleeding 5, 2
• The American Heart Association recommends not delaying aspirin administration for diagnostic confirmation, as the evidence strongly supports immediate administration for suspected ACS 1, 2

Evidence Hierarchy

• The American College of Cardiology/American Heart Association guidelines provide Class I, Level A evidence for aspirin administration immediately upon presentation with suspected unstable angina (UA)/NSTEMI 2
• The guidelines provide Class I, Level A evidence for clopidogrel administration before angiography in invasive strategy patients and after diagnosis confirmation in conservative strategy patients, according to the American College of Cardiology 5, 2